Gabapentin
Product Images NDC 71093-120

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71093-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aci Healthcare Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

An illustration showing the formula for calculating creatinine clearance (CLCr), including adjustments for age, weight, serum creatinine, and a factor for female patients.*

FDA Label Image

Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

Chemical structure of Gabapentin showing a cyclohexane ring attached to an aminomethyl group and an acetic acid moiety.*

FDA Label Image

Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

A line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin, 3600 mg/day. The x-axis represents weeks (Baseline to Week 8), and the y-axis shows mean pain scores from 0 to 10. The graph highlights a 4-week dose titration period followed by a 4-week fixed dose period, showing a decrease in pain score for Gabapentin compared to placebo.*

FDA Label Image

Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

A line graph showing mean pain scores over a 7-week period comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline through a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows the mean pain score. Gabapentin groups show lower pain scores compared to placebo throughout the study timeframe.*

FDA Label Image

Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' The graph compares placebo (PBO) versus Gabapentin (GBP) doses (1800 mg, 2400 mg, 3600 mg) across two studies, showing higher response proportions for GBP groups with percentages labeled above each bar (12%, 29%, 14%, 32%, 34%). Statistical significance is indicated by asterisks with p-values less than 0.01 and 0.001.*

FDA Label Image

Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

A scatter plot comparing the percentage difference by daily dose (mg) for three studies labeled study a, study b, and study c. The x-axis shows daily doses at 600, 900, 1200, and 1800 mg, while the y-axis shows difference percentages from 2% to 22%. Different markers represent the three studies, illustrating variations in difference percentages across doses.*

FDA Label Image

Strides 1

Gabapentin Capsules, USP 100 mg label from ACI Healthcare USA, Inc. The label indicates 500 capsules per package. It features dosage and storage instructions, manufacturer information (Strides Pharma Science Limited, India), and distributor information (ACI Healthcare USA, Inc., Coral Springs, FL). The label includes a barcode and a green and gray color scheme.*

FDA Label Image

Strides 2

Label for Gabapentin Capsules, USP 300 mg by ACI Healthcare USA, Inc. The label states the strength as 300 mg and package size of 500 capsules. Instructions note storage between 20° to 25°C and controlled room temperature. Distributed by ACI Healthcare USA, Inc. with address in Coral Springs, FL. Manufactured by Strides Pharma Science Limited, India. Contains warnings to keep medication out of reach of children.*

FDA Label Image

Strides 3

Gabapentin Capsules, USP 400 mg label by ACI Healthcare USA, Inc. The label states the product contains 400 mg gabapentin per capsule and includes handling instructions, storage conditions, and manufacturer and distributor information. The label shows a count of 500 capsules and features a barcode and NDC number 71093-122-05.*

FDA Label Image

Vivmed 1

Gabapentin Capsules, USP 100 mg label by ACI Healthcare USA, Inc. The label shows the strength (100 mg) and quantity (100 capsules). It includes storage instructions, dispensing information, manufacturer details (Vivimed Life Sciences Private Limited, India), a barcode, and spaces for batch details and expiration date. The label is primarily green and white with specified dimensions 120 x 40 mm.*

FDA Label Image

Vivmed 2

Gabapentin Capsules, USP 300 mg label by ACI Healthcare USA, Inc. The label indicates 100 capsules per container and includes dosage strength, storage instructions, barcode, and manufacturer details. It also provides a pharmacist dispensing note and a space designated for batch details and a 2D barcode.*

FDA Label Image

Vivmed 3

Label for Gabapentin Capsules, USP 400 mg by ACI Healthcare USA, Inc. The label indicates the product contains 100 capsules. It includes dosage form, strength, storage instructions, manufacturer and distributor details, a barcode, and a note to dispense the medication guide to patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.